Free Trial

Oppenheimer Asset Management Inc. Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

Oppenheimer Asset Management Inc. lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,132 shares of the company's stock after buying an additional 12,180 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Option Care Health were worth $1,717,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the period. Cornerstone Investment Partners LLC grew its stake in Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares in the last quarter. Assetmark Inc. grew its stake in Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after purchasing an additional 487 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after purchasing an additional 525 shares in the last quarter. Finally, Mackenzie Financial Corp grew its stake in Option Care Health by 1.1% during the 4th quarter. Mackenzie Financial Corp now owns 49,579 shares of the company's stock valued at $1,150,000 after purchasing an additional 556 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on OPCH. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research note on Wednesday, June 18th. Finally, Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Get Our Latest Stock Analysis on OPCH

Option Care Health Price Performance

Shares of OPCH opened at $32.25 on Friday. The firm has a market cap of $5.28 billion, a price-to-earnings ratio of 26.01, a PEG ratio of 1.93 and a beta of 0.74. The stock has a 50 day moving average of $32.06 and a 200-day moving average of $30.83. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.26 EPS. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Recommended Stories

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines